(Date:11/24/2009)...,, CALGARYandBLENHEIM,Ontario,Nov.24/PRNewswi...itisacquiringtheassetsofHylandSeeds,adivisionofTho...dSeedswillfurtherexpandDowAgroSciences,currentseed...SmartStax(TM) in 2010 andDowAgroSciencesHerbicid...nalcloseisexpectedinthenearfuture. ,, "Thisacqu...
(Date:11/24/2009)...,, SHANGHAI,Nov.24/PRNewswire-Asia/--NODPharm...ffice(PTO)hasallowedthepatentapplicationfor,itsnan...echnologyisahighlyefficientapproachtoincorporatepe...nableoraldeliveryofdrugs,otherwiseadministeredasin...nbeappliedtomanymacromoleculardrugssuchasinsulin,i...
(Date:11/24/2009)...,, ,Primaryefficacyendpointhasbeenmetforpatien... , QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AE...ny"),aglobalbiopharmaceuticalcompanyfocusedonendoc...acydatafromaPhase2studywithitstargetedcytotoxicpep...ithadvancedorrecurrentendometrialcancer.Inapersona...
(Date:11/24/2009)...,, BOZEN,Italy,November24/PRNewswire/--Health...jointventurewithagroupofselected,investors.Thisrec...,nameHealthRoboticsCanada,Inc.andwillmarket,instal...cept,whichincludesthe,revolutionaryproductoffering...boticsCanadaInc.willalsoprovideassistanceonan"asne...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2... COLUMBUS, Ohio -- Engineers at Ohio State Univers...computer chips made from the same material found i... sheet-like form of carbon found in graphite penci.... It might also deliver quantum mechanical effects...til now, most researchers could only create tiny g...
...CORONA, Calif., March 31 Watson Pharmaceuticals, ...tical company, announced today that the United Sta...s ruled that Watson,s generic version of Concerta ...blets) does not infringe United States Patent No. ...nt is invalid. The opinion, dated March 30, 2009,...
...Quantum Immunologics announces the filing of two i...A, Fla., March 31 Quantum Immunologics, Inc. (QI)...mmunotherapy, has recently filed two provisional p...r immunotherapy. , , The company,s research is f..., or more specifically, iLRP - immature Laminin Re...
Other Biology Technology:Researchers find better way to manufacture fast computer chips 2Researchers find better way to manufacture fast computer chips 3Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid 2Immunotherapy-Based Provisional Patents Mark Significant Discovery 2Immunotherapy-Based Provisional Patents Mark Significant Discovery 3...d Non-Radioactive Translation Detection Systems al...zed in vitro. Using these systems, biotinylated ly...ns during translation, eliminating the need for la...amino acids. This biotinylated lysine is added to ...
Dulbecco's Phosphate Buffered Saline (DPBS) from Sigma-Aldrich
Illumina Standard Data Analysis Report from Asuragen, Inc.
... value of your microarray data using Asuragens bio...ed from consultation to extensive data analysis us...tise in combination with the Gene Expression Profi...ts., ,Normalization and basic statistical anal...
Biology Products: